Sunovion

From Food & Medicine Encyclopedia

Sunovion Pharmaceuticals[edit]

Sunovion is a subsidiary of Sumitomo Pharma.

Sunovion Pharmaceuticals Inc. is a global biopharmaceutical company focused on the innovative application of science and medicine to help people with serious medical conditions. Sunovion is a subsidiary of Sumitomo Pharma, a leading Japanese pharmaceutical company.

History[edit]

Sunovion was established in 2010 following the acquisition of Sepracor Inc. by Dainippon Sumitomo Pharma Co., Ltd. The company has its headquarters in Marlborough, Massachusetts, and operates in various countries around the world.

Products[edit]

Sunovion develops and markets a range of pharmaceutical products primarily in the areas of psychiatry, neurology, and respiratory diseases. Some of its well-known products include:

Research and Development[edit]

Sunovion is committed to advancing research in the fields of psychiatry, neurology, and respiratory diseases. The company invests significantly in clinical trials and collaborates with academic institutions and other pharmaceutical companies to develop new therapies.

Corporate Social Responsibility[edit]

Sunovion engages in various corporate social responsibility (CSR) initiatives, focusing on improving patient access to medications, supporting community health programs, and promoting environmental sustainability.

Related pages[edit]

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.